Percutaneous Radiofrequency Ablation of Renal Parenchyma: Experimental Study on the Optimal Temperature and the Impact of Vasoactive Drugs

Nenhuma Miniatura disponível
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2011
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MARY ANN LIEBERT INC
Autores
Citação
JOURNAL OF ENDOUROLOGY, v.25, n.12, p.1895-1902, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and Purpose: Radiofrequency (RF) is an efficient, inexpensive, safe, and friendly option for the management of small renal tumors. The objective was to evaluate the ideal temperature for renal cell destruction in dogs by RF and to verify whether the injection of vasoactive drugs, such as prostaglandin E1 and adrenaline, can help to improve the results, compared with ""dry'' RF ablation. Materials and Methods: The study was divided into three phases: Initially, 16 dogs of comparable weight underwent RF ablation of the renal parenchyma at temperatures of 80 degrees C, 90 degrees C, and 100 degrees C. After that, seven other dogs received adrenaline (vasoconstrictor) and seven received prostaglandin E1 (vasodilator). Finally, the results from 14 animals were compared with those of the 16 (dry RF) dogs at the optimum temperature found. After 14 days, the animals underwent nephrectomy to evaluate the size of the lesions (width and depth), histology examination, and were then sacrificed. Results: There were no clinical or surgical complications in any of the dogs, and none died before the 14th day after the procedure. The optimum temperature was found to be 90 degrees C. Prostaglandin E1 resulted in significantly larger lesions (in depth and width) than adrenaline, with lower impedance. Prostaglandin did not increase the lesions compared with dry RF. All the kidneys presented total coagulation necrosis, with no viable cells in the histologic analysis of the treated tissue. Conclusion: In the ablation of renal cells by RF, prostaglandin produced larger lesions (in depth and width) than the same procedure using adrenaline, and its performance was similar to that of RF without injection of drugs.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/23500
Referências
  1. Goldberg SN, 1998, J VASC INTERV RADIOL, V9, P101, DOI 10.1016/S1051-0443(98)70491-9
  2. Goldberg SN, 1998, RADIOLOGY, V209, P761
  3. Gervais DA, 2003, RADIOLOGY, V226, P417, DOI 10.1148/radiol.2262012062
  4. Marcovich R, 2003, J UROLOGY, V170, P1370, DOI 10.1097/01.ju.0000073846.32015.45
  5. Hwang JJ, 2004, J UROLOGY, V171, P1814, DOI 10.1097/01.ju.0000119905.72574.de
  6. Bandi G, 2008, UROLOGY, V71, P113, DOI 10.1016/j.urology.2007.08.023
  7. Park S, 2006, J ENDOUROL, V20, P569, DOI 10.1089/end.2006.20.569
  8. Larson TR, 1996, UROLOGY, V47, P463, DOI 10.1016/S0090-4295(99)80478-6
  9. Zagoria RJ, 2007, AM J ROENTGENOL, V189, P429, DOI 10.2214/AJR.07.2258
  10. Rossi S, 1999, TUMORI, V85, P128
  11. Goldberg SN, 2001, RADIOLOGY, V219, P157
  12. Veltri A, 2009, CARDIOVASC INTER RAD, V32, P76, DOI 10.1007/s00270-008-9414-5
  13. Hui GC, 2008, J VASC INTERV RADIOL, V19, P1311, DOI 10.1016/j.jvir.2008.05.014
  14. Kunkle DA, 2008, CANCER, V113, P2671, DOI 10.1002/cncr.23896
  15. [Anonymous], 1991, PRINC ET EXP AN
  16. Bensalah K, 2008, BJU INT, V101, P467, DOI 10.1111/j.1464-410X.2007.07276.x
  17. Djavan B, 1997, UROLOGY, V50, P986, DOI 10.1016/S0090-4295(97)00540-2
  18. Varkarakis IM, 2005, J UROLOGY, V174, P456, DOI 10.1097/01.ju.0000165655.91152.c5
  19. Pandharipande PV, 2008, RADIOLOGY, V248, P169, DOI 10.1148/radiol.2481071448
  20. Mayo-Smith WW, 2003, AM J ROENTGENOL, V180, P1503
  21. Meloni MF, 2008, AM J ROENTGENOL, V191, P1233, DOI 10.2214/AJR.07.3238
  22. McDougal WS, 2005, J UROLOGY, V174, P61, DOI 10.1097/01.ju.0000162046.45024.2b
  23. Bhowmick S, 2001, J ENDOUROL, V15, P629, DOI 10.1089/089277901750426436
  24. Carey RI, 2007, J ENDOUROL, V21, P807, DOI 10.1089/end.2007.9943
  25. Friesenecker B, 2007, EUR J APPL PHYSIOL, V99, P405, DOI 10.1007/s00421-006-0360-0
  26. Frisch L, 2006, EUR RADIOL, V16, P1990
  27. Goldberg SN, 1996, ACAD RADIOL, V3, P212, DOI 10.1016/S1076-6332(96)80443-0
  28. Goldberg SN, 1998, AM J ROENTGENOL, V170, P1023
  29. Han JK, 2005, EUR RADIOL, V15, P2163, DOI 10.1007/s00330-005-2713-1
  30. Johnson D Brooke, 2003, Urology, V62, P351, DOI 10.1016/S0090-4295(03)00361-3
  31. Lee JM, 2004, KOREAN J RADIOL, V5, P258
  32. Lee JM, 2005, EUR J RADIOL, V54, P408, DOI 10.1016/j.ejrad.2004.06.004
  33. Lehman Daniel S, 2008, Curr Urol Rep, V9, P34, DOI 10.1007/s11934-008-0008-1
  34. Matlaga BR, 2002, J UROLOGY, V168, P2401, DOI 10.1097/01.ju.0000036614.65812.38
  35. McGahan J P, 1992, J Vasc Interv Radiol, V3, P291, DOI 10.1016/S1051-0443(92)72028-4
  36. Michaels MJ, 2002, J UROLOGY, V168, P2406, DOI 10.1097/01.ju.0000037915.89846.b6
  37. Park Sangtae, 2007, Cancer Control, V14, P205
  38. Queiroz M, 2009, J ENDOUROL, V23, P313, DOI 10.1089/end.2008.0195
  39. Raj GV, 2003, UROLOGY, V61, P23, DOI 10.1016/S0090-4295(02)01850-2
  40. Raman JD, 2008, CAN J UROL, V15, P3980
  41. Rehman J, 2004, J ENDOUROL, V18, P83, DOI 10.1089/089277904322836749
  42. SEEGENSCHMIEDT MH, 1990, AM J CLIN ONCOL-CANC, V13, P352, DOI 10.1097/00000421-199008000-00016
  43. Tan BJ, 2004, J UROLOGY, V172, P2007, DOI 10.1097/01.ju.0000138083.84066.98
  44. Walsh LP, 2007, UROLOGY, V70, P380, DOI 10.1016/j.urology.2007.03.007

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/55